
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes

Tuesday Jan 25, 2022
Conversation with Katelyn Dervay
Tuesday Jan 25, 2022
Tuesday Jan 25, 2022
In this episode, Vicki Basalyga sits down with Katelyn Dervay, who relays how her time and training as an Emergency Medicine Pharmacist and experience on medical missions in Haiti translates to caring for patients as a Civilian Inpatient Pharmacist at Landstuhl Regional Medical Center. Katelyn shares what shaped her career, what she has learned along the way and how she integrated what she was passionate about into an exciting and dynamic pharmacy career.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Jan 24, 2022
Monday Jan 24, 2022
In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Jan 21, 2022
Managing Biosimilars: A Specialty All Its Own
Friday Jan 21, 2022
Friday Jan 21, 2022
In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Jan 20, 2022
Thursday Jan 20, 2022
In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Jan 14, 2022
2022 ASHP/ASHP Foundation Pharmacy Forecast
Friday Jan 14, 2022
Friday Jan 14, 2022
Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Thursday Jan 13, 2022
Become a Wiz at Urine Drug Screens (UDS)
Thursday Jan 13, 2022
Thursday Jan 13, 2022
This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Wednesday Jan 12, 2022
Wednesday Jan 12, 2022
Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tuesday Jan 11, 2022
Community Pharmacy: The Path to Leadership
Tuesday Jan 11, 2022
Tuesday Jan 11, 2022
In this podcast we discuss with Dr. Andrea Luebchow, Program Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Monday Jan 10, 2022
International Pharmacy Leadership
Monday Jan 10, 2022
Monday Jan 10, 2022
In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Friday Jan 07, 2022
Pharmacy Informatics Women Leaders: Distinguished Service
Friday Jan 07, 2022
Friday Jan 07, 2022
Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
